Germany
Japan
United Kingdom
China
Rabbit monoclonal anti-P5CR1 antibody for SISCAPA, clone OTIR1E8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Products
Download
Rabbit monoclonal anti-AAAT antibody for SISCAPA, clone OTIR5A7
| Applications | SISCAPA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CATB antibody for SISCAPA, clone OTIR1C4
| Applications | SISCAPA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CDKN2A / p16INK4A (anti-CD2A1) antibody for SISCAPA, clone OTIR3C4
| Applications | SISCAPA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CADH6 antibody for SISCAPA, clone OTIR5A6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-OFLM4 antibody for SISCAPA, clone OTIR2A11
| Applications | SISCAPA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CHK1 antibody for SISCAPA, clone OTIR3G7
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-ERK3 antibody for SISCAPA, clone OTIR5F3
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-FOXO1 antibody for SISCAPA, clone OTIR3H6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 524.00
In Stock
MMP9 rabbit monoclonal antibody, clone EP1255Y, Supernatant
| Applications | IF, IHC, WB |
| Reactivities | Guinea Pig, Human |
Rabbit Monoclonal Anti-Mouse IgG1 antibody, clone RM106
| Applications | ELISA: 0.005ug/mL – 0.2ug/mL, ICC, IHC: 0.5ug/mL-2ug/mL, WB: 0.1ug/mL-0.5ug/mL |
| Reactivities | Mouse IgG1 |
| Conjugation | Unconjugated |
Rabbit Monoclonal Anti-Human IgG1 Antibody, Clone RM117
| Applications | ELISA: 50ng/well - 200ng/well for Capture;, 0.05ug/mL - 0.2ug/mL for Detection;, ICC: 0.5ug/mL-2ug/mL, IHC: 0.5ug/mL-2ug/mL |
| Reactivities | Human IgG1 |
| Conjugation | Unconjugated |
Rabbit Monoclonal Anti-Human IgM antibody, clone RM121
| Applications | ELISA: 50ng/well – 200ng/well (for Capture);0.05ug/mL – 0.2ug/mL (for Detection); IHC, ICC: 0.5ug/mL – 2ug/mL |
| Reactivities | Human IgM |
| Conjugation | Unconjugated |
Rabbit Monoclonal Anti-Human IgA antibody, clone RM128
| Applications | ELISA: 50ng/well – 200ng/well (for Capture); 0.05ug/mL – 0.2ug/mL (for Detection); IHC, ICC: 0.5ug/mL – 2ug/mL |
| Reactivities | Human IgA |
| Conjugation | Unconjugated |
USD 515.00
In Stock
Negative Control for Rabbit IgG
Caldesmon (CALD1) rabbit monoclonal antibody, clone EP19, Supernatant
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Rabbit monoclonal anti-Myc tag Antibody, clone OTIR4H8
| Applications | WB |
Active filters
Antibody Hosts
- Rabbit
Clonalities
- Monoclonal
Filter by
Target Symbol
- CAPSID (50)
- S PROTEIN (47)
- N PROTEIN (40)
- AMH (34)
- MAPT (34)
- NPPB (21)
- EGFR (12)
- BCL2 (11)
- DDK (10)
- CD274 (8)
- CD8A (8)
- CD3E (7)
- CD40LG (7)
- H2AX (7)
- IL2RA (7)
- AAV8 (6)
- BCL6 (6)
- CASP3 (6)
- CD38 (6)
- CD4 (6)
- CD40 (6)
- E-CADHERIN(CDH1) (6)
- G6PC1 (6)
- GATA6 (6)
- H3-3A (6)
- HNF1-BETA(HNF1B) (6)
- HSD17B13 (6)
- MUC1 (6)
- SARS-COV-2 SPIKE PROTEIN (6)
- SMARCA4 (6)
- SMARCB1 (6)
- CD99 (5)
- HSPB1 (5)
- MYC (5)
- S (5)
- TNFRSF17 (5)
- AAV2 (4)
- AAV5 (4)
- CCR5 (4)
- CD163 (4)
- CD19 (4)
- CD22 (4)
- CD37 (4)
- CD44 (4)
- CD52 (4)
- CD80 (4)
- EIF4E (4)
- GLUL (4)
- HIGG LAMBDA LIGHT CHAIN (4)
- IL3RA (4)
- ITGB2 (4)
- MAPK14 (4)
- MIGG (1,2A,2B,3) (4)
- MIGG2A (4)
- MSLN (4)
- MUC6 (4)
- NFASC (4)
- NFKBIA (4)
- P40 (4)
- PNPLA3 (4)
- PSCA (4)
- SOX2 (4)
- STAT3 (4)
- UBB (4)
- VEGFA (4)
- YAP1 (4)
- ACTA1 (3)
- APP (3)
- ATF2 (3)
- BAX (3)
- CCNB1 (3)
- CD28 (3)
- CD63 (3)
- CD74 (3)
- CDK4 (3)
- CDKN2A (3)
- CR1 (3)
- CTNND1 (3)
- DDK (FLAG) (3)
- ENO1 (3)
- ERBB2 (3)
- ESR1 (3)
- HIS (3)
- IL18 (3)
- IL9 (3)
- INSR (3)
- ITGA2B (3)
- LDHA (3)
- LGALS3 (3)
- MAP2K1 (3)
- MAPK1 (3)
- PIP (3)
- PRDX2 (3)
- PTGS2 (3)
- SLAMF7 (3)
- SMAD3 (3)
- TNF (3)
- UCHL1 (3)
- VCAM1 (3)
- VSIR (3)
Reactivities
- Human (1389)
- Mouse (675)
- Rat (556)
- SARS-CoV-2 (87)
- HIV (49)
- Hamster (35)
- Monkey (17)
- C-term DDK (10)
- Vertebrates (9)
- Adenovirus 8 (6)
- Cow (6)
- Rabbit (6)
- All Species (5)
- Adenovirus 5 (4)
- Bovine (4)
- Chimpanzee (4)
- Dog (4)
- Pig (4)
- Sheep (4)
- Adenovirus (2)
- Adenovirus 9 (2)
- Chicken (2)
- Cynomolgus (2)
- Goat (2)
- Guinea Pig (2)
- N-term and C-term DDK (2)
- Primate (2)
- SARS-CoV (2)
- Baboon (1)
- Dengue virus (1)
- Drosophila melanogaster (1)
- Escherichia coli (1)
- Feline (1)
- Ferret (1)
- Macaque (1)
- Marmoset (1)
- Respiratory Syncytial Virus (1)
- Saccharomyces cerevisiae (1)
- Virus (1)
- West Nile Virus (1)
- Yellow Fever Virus (1)
- Zebrafish (1)
Applications
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (94)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (36)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (27)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (23)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (20)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (18)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- Phospho-specific (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (303)
- Secreted Protein (104)
- Transmembrane (88)
- Transcription Factors (69)
- ES Cell Differentiation/IPS (62)
- Stem cell - Pluripotency (40)
- Embryonic stem cells (20)
- Protein Kinase (17)
- Adult stem cells (16)
- Induced pluripotent stem cells (10)
- Protease (10)
- Cancer stem cells (9)
- Nuclear Hormone Receptor (6)
- Stem cell relevant signaling - DSL/Notch pathway (5)
- Phosphatase (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (4)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (2)
- GPCR (1)
Pathways
- Pathways in cancer (46)
- Cytokine-cytokine receptor interaction (39)
- MAPK signaling pathway (39)
- TGF-beta signaling pathway (37)
- Alzheimer's disease (30)
- Metabolic pathways (29)
- Focal adhesion (27)
- Cell adhesion molecules (CAMs) (26)
- Insulin signaling pathway (22)
- Neurotrophin signaling pathway (20)
- Prostate cancer (20)
- Colorectal cancer (18)
- Hematopoietic cell lineage (16)
- Leukocyte transendothelial migration (16)
- Regulation of actin cytoskeleton (16)
- Small cell lung cancer (16)
- Apoptosis (15)
- Amyotrophic lateral sclerosis (ALS) (13)
- ErbB signaling pathway (13)
- Melanoma (13)
- Acute myeloid leukemia (12)
- Adipocytokine signaling pathway (12)
- Endometrial cancer (12)
- Chronic myeloid leukemia (11)
- Jak-STAT signaling pathway (11)
- Glioma (10)
- Natural killer cell mediated cytotoxicity (10)
- Pancreatic cancer (10)
- Bladder cancer (9)
- Non-small cell lung cancer (9)
- mTOR signaling pathway (9)
- Glycolysis / Gluconeogenesis (8)
- Parkinson's disease (8)
- Primary immunodeficiency (8)
- Renal cell carcinoma (8)
- T cell receptor signaling pathway (8)
- Antigen processing and presentation (7)
- Arginine and proline metabolism (7)
- B cell receptor signaling pathway (7)
- Cell cycle (7)
- Chemokine signaling pathway (7)
- Endocytosis (7)
- Hypertrophic cardiomyopathy (HCM) (7)
- Starch and sucrose metabolism (7)
- Systemic lupus erythematosus (7)
- VEGF signaling pathway (7)
- Wnt signaling pathway (7)
- p53 signaling pathway (7)
- Alanine (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (6)
- Dilated cardiomyopathy (6)
- Galactose metabolism (6)
- Long-term potentiation (6)
- Melanogenesis (6)
- Phosphatidylinositol signaling system (6)
- Progesterone-mediated oocyte maturation (6)
- Toll-like receptor signaling pathway (6)
- Type II diabetes mellitus (6)
- Viral myocarditis (6)
- aspartate and glutamate metabolism (6)
- Adherens junction (5)
- Basal cell carcinoma (5)
- Calcium signaling pathway (5)
- Epithelial cell signaling in Helicobacter pylori infection (5)
- Huntington's disease (5)
- Inositol phosphate metabolism (5)
- Nitrogen metabolism (5)
- Oocyte meiosis (5)
- Phenylalanine metabolism (5)
- Thyroid cancer (5)
- Tight junction (5)
- Vascular smooth muscle contraction (5)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Glycerolipid metabolism (4)
- Glycerophospholipid metabolism (4)
- Hedgehog signaling pathway (4)
- Limonene and pinene degradation (4)
- Maturity onset diabetes of the young (4)
- Pathogenic Escherichia coli infection (4)
- Prion diseases (4)
- Tyrosine metabolism (4)
- Complement and coagulation cascades (3)
- ECM-receptor interaction (3)
- GnRH signaling pathway (3)
- Long-term depression (3)
- Ubiquitin mediated proteolysis (3)
- Cysteine and methionine metabolism (2)
- Dorso-ventral axis formation (2)
- Gap junction (2)
- Mismatch repair (2)
- NOD-like receptor signaling pathway (2)
- Non-homologous end-joining (2)
- Notch signaling pathway (2)
- Nucleotide excision repair (2)
- ABC transporters (1)
- Axon guidance (1)
- Cardiac muscle contraction (1)
- DNA replication (1)
- Folate biosynthesis (1)
- Glutathione metabolism (1)
- Homologous recombination (1)
- Lysosome (1)
- Methane metabolism (1)
- Neuroactive ligand-receptor interaction (1)
- Nicotinate and nicotinamide metabolism (1)
- Olfactory transduction (1)
- One carbon pool by folate (1)
- PPAR signaling pathway (1)
- Pentose phosphate pathway (1)
- Propanoate metabolism (1)
- Pyruvate metabolism (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of autophagy (1)
- Renin-angiotensin system (1)
- Terpenoid backbone biosynthesis (1)
- Vibrio cholerae infection (1)